Pharmaceutical Product Development – better known as PPD in Wilmington – announced this morning that it’s Board of Directors has named a new chairman and CEO.
PPD’s new CEO Raymond Hill resigned Monday after only three months at his post and just a week after the company went private.
The $3.9 billion acquisition of PPD by the Carlyle Group and Hellman and Friedman is now complete.